SAMABRIVA BIOMANUFACTURING
1002.863.501 · rovalta.com · 24/09/2026
SAMABRIVA BIOMANUFACTURING
Company — Voluntary dissolution - liquidation.
Strike-off: 23 septembre 2026
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOSAMABRIVA BIOMANUFACTURING is a Public limited company incorporated in 2023. Its registered office is in Liège.
- Legal situation
- Voluntary dissolution - liquidation
- BCE/KBO no. / VAT
- BE 1002.863.501
- Incorporation
- 30/11/2023
- Legal form
- Public limited company
- Registered office
- Avenue Pré-Aily 14
4031 Liège · WallonieSee on map - Contributed capital
- 150 000,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 207
Financials
Source · NBB, 2 filingsTrend over 2 financial years
| 2025 | 2024 | ||
|---|---|---|---|
| Income statement | |||
| Gross margin | -472,6 k € | -5.4% | -448,4 k € |
| EBITDA | -623,9 k € | -29.1% | -483,1 k € |
| Operating result | -636,2 k € | -30.7% | -486,8 k € |
| Net result | -722 k € | -32.6% | -544,5 k € |
| Balance sheet | |||
| Equity | -933,5 k € | -183% | -329,8 k € |
| Total assets | 1,1 M € | -53.0% | 2,3 M € |
| Cash | 393,4 k € | -79.9% | 2 M € |
| Debts | 1,9 M € | -24.5% | 2,6 M € |
Board of directors
Source · NBB, accounts to 31/12/2025Other companies at this address
Avenue Pré-Aily 14 4031 Liège| Company | CBE no. |
|---|---|
IMCYSE● Liquidation | 0828.385.542 |
Signatur Biosciences● Active | 1019.094.272 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | |
|---|---|---|
| Type of account | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 30/11/2023 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 |
| Length of the financial year | 12 months | 14 months |
| Filing date | 08/06/2026 | 26/05/2025 |
| General meeting | 04/05/2026 | 02/05/2025 |
| Currency of the financial year | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 2 filingsValuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-722 k €↓
- 2024Annual accounts 2024-544,5 k €
- 30/11/2023IncorporationPublic limited company